{
    "clinical_study": {
        "@rank": "63796", 
        "arm_group": [
            {
                "arm_group_label": "Patients with type 2 diabetes mellitus (T2DM)"
            }, 
            {
                "arm_group_label": "Healthcare professionals (HCPs)"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is conducted Asia, Europe and North America. The aim of this study is to describe\n      insulin therapy adherence and the burden of non-adherence on patient functioning, well-being\n      and diabetes management."
        }, 
        "brief_title": "GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Diabetes", 
            "Diabetes Mellitus, Type 2"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  PATIENTS WITH T2DM:\n\n          -  Diagnosed with type 2 diabetes by a healthcare professional\n\n          -  Currently being treated with insulin medication, excluding premix insulin treatment\n\n          -  Age at least 40 years\n\n          -  Diagnosed as having type 2 diabetes over the age of 40\n\n          -  HCPs:\n\n          -  Primary care physician, diabetes specialist (diabetologist/endocrinologist) or\n             diabetes specialist nurse/diabetes nurse educator\n\n          -  Have a minimum of 2 years experience within current speciality\n\n          -  See a minimum of 20 type 2 diabetes patients per month (40 for diabetes specialists),\n             of which at least 10 per month must be on modern (analogue) inulins"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Insulin treated patients with type 2 diabetes, and HCPs involved in the treatment,\n        management of diabetes and care of patients with type 2 diabetes."
            }
        }, 
        "enrollment": {
            "#text": "4000", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01950637", 
            "org_study_id": "GAPP2", 
            "secondary_id": "U1111-1136-2536"
        }, 
        "intervention": [
            {
                "arm_group_label": "Patients with type 2 diabetes mellitus (T2DM)", 
                "description": "Completion of 90-item online questionnaire.", 
                "intervention_name": "No treatment given", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Healthcare professionals (HCPs)", 
                "description": "Completion of 58-item online questionnarie.", 
                "intervention_name": "survey", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 15, 2014", 
        "link": {
            "description": "Clinical Trials at Novo Nordisk", 
            "url": "http://novonordisk-trials.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Princeton", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08540"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mississauga", 
                        "country": "Canada", 
                        "zip": "L4W 4XI"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Copenhagen S", 
                        "country": "Denmark", 
                        "zip": "2300"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mainz", 
                        "country": "Germany", 
                        "zip": "55127"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tokyo", 
                        "country": "Japan", 
                        "zip": "1000005"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Crawley", 
                        "country": "United Kingdom", 
                        "zip": "RH11 9RT"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada", 
                "Denmark", 
                "Germany", 
                "Japan", 
                "United Kingdom"
            ]
        }, 
        "number_of_groups": "2", 
        "official_title": "GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus", 
        "overall_official": {
            "affiliation": "Novo Nordisk A/S", 
            "last_name": "Global Clinical Registry (GCR, 1452)", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Canada: Health Canada", 
                "Denmark: Danish Medicines Agency", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Japan: Ministry of Health, Labor and Welfare", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Basal insulin dosing irregularities: frequency of missed doses, mistimed doses, or reduced doses (patient questionnaire)", 
                "safety_issue": "No", 
                "time_frame": "In the past 30 days prior to the day when responding to the online questionnaire"
            }, 
            {
                "measure": "Level of patient dosing irregularity: missed, mistimed and reduced dose (HCP questionnaire)", 
                "safety_issue": "No", 
                "time_frame": "Day 1 (when responding to the online questionnaire)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01950637"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Incidence of intentional dosing irregularities and reasons for this behaviour", 
                "safety_issue": "No", 
                "time_frame": "Day 1 (when responding to the online questionnaire)"
            }, 
            {
                "measure": "Impact of dosing irregularity on functional well-being", 
                "safety_issue": "No", 
                "time_frame": "Day 1 (when responding to the online questionnaire)"
            }, 
            {
                "measure": "Frequency of self-treated hypoglycaemia", 
                "safety_issue": "No", 
                "time_frame": "In the past 30 days prior to the day when responding to the online questionnaire"
            }
        ], 
        "source": "Novo Nordisk A/S", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novo Nordisk A/S", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}